妊娠期COVID-19诊断时间与母胎结局之间的关系:一项回顾性研究

Spartan medical research journal Pub Date : 2025-05-30 eCollection Date: 2025-01-01 DOI:10.51894/001c.140342
Sathiyakala Rajendiran, Caitlin Brazda, Morgan A Dalm
{"title":"妊娠期COVID-19诊断时间与母胎结局之间的关系:一项回顾性研究","authors":"Sathiyakala Rajendiran, Caitlin Brazda, Morgan A Dalm","doi":"10.51894/001c.140342","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To examine the relationship between COVID-19 diagnosis timing during pregnancy and adverse maternal and fetal outcomes.</p><p><strong>Methods: </strong>Pregnant women diagnosed with COVID-19 by a nasopharyngeal swab SARS-CoV-2 PCR between January 1, 2021, and December 31, 2021, irrespective of the pregnancy outcome, were included in the study. Patients not diagnosed with COVID-19 were included as a comparison group. The timing of COVID diagnosis was categorized by trimester (first trimester, <13 weeks; second trimester, 13 to <27 weeks; third trimester, >27 weeks). Maternal outcomes included placental abnormalities, HELLP syndrome, deep vein thrombosis, pulmonary embolism, and maternal death. Fetal outcomes included pregnancy loss, intrauterine growth restriction, preterm birth, stillbirth, and admission to the NICU. Quantitative data were analyzed using a one-way ANOVA and are presented as mean ± standard deviation (SD). Nominal data were compared using chi-square or Fisher's exact tests and are reported as frequency (percent). Statistical significance was set at p < 0.05.</p><p><strong>Results: </strong>A total of 289 COVID-affected pregnancies and 1706 non-COVID-19 pregnancies were included. Most patients, 189 (65.4%), were diagnosed with COVID-19 in the third trimester, 66 (22.8%) in the second trimester, and 34 (11.8%) in the first trimester. There was a statistically significant higher proportion of patients experiencing placental abnormalities in patients diagnosed with COVID-19 in the 3rd trimester with lowest occurrence in non-COVID-19 pregnancies, followed by patients diagnosed in the 1st and 2nd trimesters (p<0.001). Further, preterm delivery followed a similar frequency pattern, occurring most often in patients diagnosed with COVID-19 in the 3rd trimester (p<0.001).</p><p><strong>Conclusion: </strong>Patients with COVID-19 infection in the third trimester of pregnancy face a heightened risk of adverse maternal-fetal outcomes. Further investigation into this relationship is warranted.</p>","PeriodicalId":74853,"journal":{"name":"Spartan medical research journal","volume":"10 1","pages":"23-29"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between Timing of COVID-19 Diagnosis in Pregnancy and Maternal-Fetal Outcomes: A Retrospective Study.\",\"authors\":\"Sathiyakala Rajendiran, Caitlin Brazda, Morgan A Dalm\",\"doi\":\"10.51894/001c.140342\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To examine the relationship between COVID-19 diagnosis timing during pregnancy and adverse maternal and fetal outcomes.</p><p><strong>Methods: </strong>Pregnant women diagnosed with COVID-19 by a nasopharyngeal swab SARS-CoV-2 PCR between January 1, 2021, and December 31, 2021, irrespective of the pregnancy outcome, were included in the study. Patients not diagnosed with COVID-19 were included as a comparison group. The timing of COVID diagnosis was categorized by trimester (first trimester, <13 weeks; second trimester, 13 to <27 weeks; third trimester, >27 weeks). Maternal outcomes included placental abnormalities, HELLP syndrome, deep vein thrombosis, pulmonary embolism, and maternal death. Fetal outcomes included pregnancy loss, intrauterine growth restriction, preterm birth, stillbirth, and admission to the NICU. Quantitative data were analyzed using a one-way ANOVA and are presented as mean ± standard deviation (SD). Nominal data were compared using chi-square or Fisher's exact tests and are reported as frequency (percent). Statistical significance was set at p < 0.05.</p><p><strong>Results: </strong>A total of 289 COVID-affected pregnancies and 1706 non-COVID-19 pregnancies were included. Most patients, 189 (65.4%), were diagnosed with COVID-19 in the third trimester, 66 (22.8%) in the second trimester, and 34 (11.8%) in the first trimester. There was a statistically significant higher proportion of patients experiencing placental abnormalities in patients diagnosed with COVID-19 in the 3rd trimester with lowest occurrence in non-COVID-19 pregnancies, followed by patients diagnosed in the 1st and 2nd trimesters (p<0.001). Further, preterm delivery followed a similar frequency pattern, occurring most often in patients diagnosed with COVID-19 in the 3rd trimester (p<0.001).</p><p><strong>Conclusion: </strong>Patients with COVID-19 infection in the third trimester of pregnancy face a heightened risk of adverse maternal-fetal outcomes. Further investigation into this relationship is warranted.</p>\",\"PeriodicalId\":74853,\"journal\":{\"name\":\"Spartan medical research journal\",\"volume\":\"10 1\",\"pages\":\"23-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Spartan medical research journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51894/001c.140342\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spartan medical research journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51894/001c.140342","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨妊娠期COVID-19诊断时机与不良母婴结局的关系。方法:将2021年1月1日至2021年12月31日期间通过鼻咽拭子SARS-CoV-2 PCR诊断为COVID-19的孕妇纳入研究,无论其妊娠结局如何。未诊断为COVID-19的患者作为对照组。COVID诊断时间按妊娠进行分类(妊娠早期,27周)。产妇结局包括胎盘异常、HELLP综合征、深静脉血栓形成、肺栓塞和产妇死亡。胎儿结局包括流产、宫内生长受限、早产、死产和入住新生儿重症监护病房。定量数据采用单因素方差分析,以均数±标准差(SD)表示。标称数据使用卡方检验或Fisher精确检验进行比较,并以频率(百分比)报告。p < 0.05为差异有统计学意义。结果:共纳入新冠肺炎感染妊娠289例,非新冠肺炎妊娠1706例。确诊病例中,晚期确诊病例189例(65.4%),晚期确诊病例66例(22.8%),晚期确诊病例34例(11.8%)。诊断为COVID-19的妊娠晚期出现胎盘异常的患者比例较高,其中非COVID-19妊娠发生率最低,其次为妊娠早期和妊娠中期(p结论:妊娠晚期感染COVID-19的患者出现不良母胎结局的风险较高。有必要进一步调查这种关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Association between Timing of COVID-19 Diagnosis in Pregnancy and Maternal-Fetal Outcomes: A Retrospective Study.

Objective: To examine the relationship between COVID-19 diagnosis timing during pregnancy and adverse maternal and fetal outcomes.

Methods: Pregnant women diagnosed with COVID-19 by a nasopharyngeal swab SARS-CoV-2 PCR between January 1, 2021, and December 31, 2021, irrespective of the pregnancy outcome, were included in the study. Patients not diagnosed with COVID-19 were included as a comparison group. The timing of COVID diagnosis was categorized by trimester (first trimester, <13 weeks; second trimester, 13 to <27 weeks; third trimester, >27 weeks). Maternal outcomes included placental abnormalities, HELLP syndrome, deep vein thrombosis, pulmonary embolism, and maternal death. Fetal outcomes included pregnancy loss, intrauterine growth restriction, preterm birth, stillbirth, and admission to the NICU. Quantitative data were analyzed using a one-way ANOVA and are presented as mean ± standard deviation (SD). Nominal data were compared using chi-square or Fisher's exact tests and are reported as frequency (percent). Statistical significance was set at p < 0.05.

Results: A total of 289 COVID-affected pregnancies and 1706 non-COVID-19 pregnancies were included. Most patients, 189 (65.4%), were diagnosed with COVID-19 in the third trimester, 66 (22.8%) in the second trimester, and 34 (11.8%) in the first trimester. There was a statistically significant higher proportion of patients experiencing placental abnormalities in patients diagnosed with COVID-19 in the 3rd trimester with lowest occurrence in non-COVID-19 pregnancies, followed by patients diagnosed in the 1st and 2nd trimesters (p<0.001). Further, preterm delivery followed a similar frequency pattern, occurring most often in patients diagnosed with COVID-19 in the 3rd trimester (p<0.001).

Conclusion: Patients with COVID-19 infection in the third trimester of pregnancy face a heightened risk of adverse maternal-fetal outcomes. Further investigation into this relationship is warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信